Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Walters

Showing results (401-410 of 686) with videos related to

Pageof 69
Sort By:
British Journal of Cancer|September 20, 2000
Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumoursL Bergman, C Boothroyd, J Palmer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulationG I Hockings, J E Grice, G V Crosbie, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in manD J Torpy, J E Grice, G I Hockings, et al.
Health Promotion Practice|February 15, 2025
The Prevention Education Partnership: A Public-Academic Partnership to Expand Overdose Education and Naloxone Training in New York City Public SchoolsLarissa K Laskowski, Mehrdad Khezri, Alex S Bennett, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
Frontiers in Oncology|July 11, 2022
NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor GrowthFrederic A Vallejo, Anthony Sanchez, Branko Cuglievan, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1995
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophyJ E Grice, R V Jackson, G I Hockings, et al.
Environmental Science & Technology|September 2, 2020
Uranium Bioaccumulation Dynamics in the Mayfly <i>Neocloeon triangulifer</i> and Application to Site-Specific PredictionBrianna L Henry, Marie-Noële Croteau, David M Walters, et al.
Plos One|October 8, 2025
Disclosing HIV status to sexual partner: Findings from a People Living with HIV Stigma Index 2.0 study in the country GeorgiaTamar Zurashvili, Mariam Pashalishvili, Valerie A Earnshaw, et al.
Pageof 69

Showing results (401-410 of 686) with videos related to

Sort By:
Pageof 69
British Journal of Cancer|September 20, 2000
Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumoursL Bergman, C Boothroyd, J Palmer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulationG I Hockings, J E Grice, G V Crosbie, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in manD J Torpy, J E Grice, G I Hockings, et al.
Health Promotion Practice|February 15, 2025
The Prevention Education Partnership: A Public-Academic Partnership to Expand Overdose Education and Naloxone Training in New York City Public SchoolsLarissa K Laskowski, Mehrdad Khezri, Alex S Bennett, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
Frontiers in Oncology|July 11, 2022
NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor GrowthFrederic A Vallejo, Anthony Sanchez, Branko Cuglievan, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1995
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophyJ E Grice, R V Jackson, G I Hockings, et al.
Environmental Science & Technology|September 2, 2020
Uranium Bioaccumulation Dynamics in the Mayfly <i>Neocloeon triangulifer</i> and Application to Site-Specific PredictionBrianna L Henry, Marie-Noële Croteau, David M Walters, et al.
Plos One|October 8, 2025
Disclosing HIV status to sexual partner: Findings from a People Living with HIV Stigma Index 2.0 study in the country GeorgiaTamar Zurashvili, Mariam Pashalishvili, Valerie A Earnshaw, et al.
Pageof 69